39.20 USD
▼-0.25-0.63%
盘后 41.10 0.00%
2026-11-19
市值
$1.84B
市盈率
—
EPS
-1.31
股息率
—
52 周区间
21.63 – 53.34
成交量
209.02K
Beta
2.20
目标价
59.56
52W 低 21.6352W 高 53.34
价格走势
公司简介
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM f...